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Abstract Based on the high electron transfer rate between the
[2Fe-2S] cluster and heme c1 and the elevation of the redox
midpoint potential of iron sulfur protein (ISP) upon binding of
certain Qo inhibitors, the binding rate constants of stigmatellin
and UHDBT to the cytochrome bc1 complex were determined
using a stopped-flow rapid scanning technique. Assuming that the
intramolecular electron transfer from ISP to cytochrome c1 is
much faster than the binding of inhibitors, the rate of the
inhibitor binding can be determined by the rate of cytochrome c1
oxidation. The binding rate constants were calculated to be
1.0U105 and 2.3U105 M31 s31 at pH 7.5 for stigmatellin and
UHDBT, respectively. The binding rate constant of UHDBT is
pH dependent and that of stigmatellin is not.
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1. Introduction
Structural and functional studies of the complicated mito-
chondrial electron transfer systems require multiple ap-
proaches. In addition to conventional biochemical and bio-
physical studies [1^4], the use of speci¢c inhibitors has
greatly facilitated the establishment of electron transfer path-
way [5^7]. Owing partially to the inhibitor studies, the proton
motive Q-cycle mechanism has become accepted as the mech-
anism of electron transfer and proton translocation of the
cytochrome bc1 complex [8,9]. The inhibitors of the cyto-
chrome bc1 complex are classi¢ed into Qo and Qi inhibitors
[10], depending on their site of action in the complex. The Qi
site inhibitors, such as antimycin and 2-n-nonyl-4-hydroxyqui-
noline-N-oxide (NQNO), prevent binding of ubiquinone at
the Qi site. The Qo site inhibitors, such as 5-n-undecyl-6-hy-
droxy-4,7-dioxobenzothiazole (UHDBT), stigmatellin, myxo-
thiazol and (E)-L-methoxyacrylate-stilbene (MOA-stilbene),
block the binding of ubiquinol to the Qo site and thus inhibit
electron transfer through this site.
On the basis of structural observations [11^14], the Qo site
inhibitors are further divided into three categories: Qo-I, Qo-
II and Qo-III [12]. Myxothiazol (Qo-I) does not change the
redox midpoint potential (Em) of the [2Fe-2S] cluster [5,6]
whereas MOA-stilbene (Qo-I) slightly decreases the Em. Stig-
matellin (Qo-III) increases the Em of the [2Fe-2S] cluster by
250 mV and UHDBT (Qo-II) increases the Em by 70 mV [6].
The Qo-II and Qo-III inhibitors bind closer to the [2Fe-2S]
cluster and Qo-I inhibitors bind closer to the heme bL. The
binding of the Qo site inhibitors has considerable in£uence on
the mobility of the head domain of iron sulfur protein (ISP).
Binding of the Qo-I inhibitors increases the mobility of the
head domain of ISP, as indicated by abolishing the anomalous
signal for the [2Fe-2S] cluster in the electron density map [12].
In contrast to the Qo-I inhibitors, the Qo-II or Qo-III inhib-
itors cause a decrease of the mobility of the head domain of
ISP.
Although biochemical and spectral studies of inhibitors
have been extensive [10], the binding kinetics of the inhibitors
have not been investigated. Taking advantage of the change of
the Em of ISP upon binding of the Qo-II and Qo-III inhibitors
and the fast electron transfer between the [2Fe-2S] cluster and
heme c1, we have employed a stopped-£ow rapid scanning
technique [15,16] to determine the binding kinetics of the
Qo-II and Qo-III inhibitors, stigmatellin and UHDBT, by
measuring the rate of cytochrome c1 oxidation. The rapid
mixing methodology applied here allows monitoring of the
oxidation or reduction of cytochrome c1 with a time resolu-
tion of 1 ms after a dead time for mixing of 2 ms. Assuming
that the binding kinetics of the inhibitors mimic substrate
binding kinetics, the obtained data may be useful in the
elucidation of the reaction mechanism of ubiquinol oxidation.
2. Materials and methods
2.1. Reagents and chemicals
Cytochrome c, type III, and sodium cholate were purchased from
Sigma. Stigmatellin was purchased from Fluka. 2,3-Dimethoxyl-5-
methyl-6-geranyl-1,4-benzoquinone (Q2), and its reduced form
(Q2H2) [17] and UHDBT [7] were synthesized as previously reported.
Other chemicals were of the highest commercially available purity.
2.2. Bovine cytochrome bc1 complex
The puri¢ed cytochrome bc1 complex was prepared as previously
reported [18]. It was dissolved in 50 mM Tris-HCl bu¡er, pH 7.8,
containing 0.66 M sucrose to a protein concentration of 20 mg/ml
and frozen at 380‡C until use. The puri¢ed enzyme contains 10
nmol cytochrome b and 5.7 nmol cytochrome c1 per mg protein.
The complex as prepared is partially reduced with 60% of cytochrome
c1 and 83% of ISP in the reduced state.
2.3. Enzyme activity assay
The puri¢ed cytochrome bc1 complex was dissolved in 50 mM K/
Na phosphate bu¡er, pH 7.4, containing 0.01% dodecyl maltoside
and 1 mM EDTA to a protein concentration of 0.025 mg/ml. The
assay mixture contains 50 mM K/Na phosphate bu¡er, pH 7.4,
1 mM EDTA, 100 WM cytochrome c, and 25 WM Q2H2. The activity
was determined by measuring the reduction of cytochrome c (the
increase of absorbance at 550 nm) in a Shimadzu UV 2101 PC spec-
trophotometer at room temperature. A millimolar extinction coe⁄-
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cient of 18.5 was used to calculate the activity. Non-enzymatic oxida-
tion of Q2H2, determined under the same conditions in the absence of
enzyme, was subtracted.
2.4. Determination of the binding rate of the inhibitors
The cytochrome bc1 complex was diluted in 20 mM Tris-HCl bu¡-
er, with various pHs (7.5, 8.3 and 9.2), containing 0.05% dodecyl
maltoside and 0.1 M KCl to a cytochrome c1 concentration of 7.5
WM and mixed with various concentrations (44^144 WM) of the in-
hibitors (stigmatellin or UHDBT) in the same bu¡er at room temper-
ature in an Olis stopped-£ow rapid scanning spectrophotometer. Ox-
idation of cytochrome c1 was monitored by a decrease of absorption
at 553.4 nm. A millimolar extinction coe⁄cient of 17.5 was used in
calculating the concentration of cytochrome c1.
3. Results and discussion
3.1. pH or inhibitors induced electron transfer between the
[2Fe-2S] cluster and heme c1 in the native cytochrome
bc1 complex
The Em of the [2Fe-2S] cluster is pH dependent and that of
cytochrome c1 is not. As pH decreases, the Em of the [2Fe-2S]
cluster increases [19]. At pH 7 the Em of the ISP is 290 mV
and that of cytochrome c1 is 228 mV. At pH 8 the ISP and
cytochrome c1 have approximately the same Em. When a cy-
tochrome c1 partially reduced cytochrome bc1 complex at pH
8.0 was mixed with dilute acid to lower its pH to 7.0, oxida-
tion of cytochrome c1 was observed. On the other hand, when
the pH of the enzyme solution was increased, cytochrome c1
became more reduced, presumably at the expense of the oxi-
dation of ISP. The rate of this acid/base induced electron
transfer, from cytochrome c1 to ISP and vice versa, is greater
than what can be determined accurately by a conventional
stopped-£ow apparatus [20].
Upon the binding of stigmatellin to the cytochrome bc1
complex, the Em of the ISP is raised by 250 mV [6] whereas
that of the cytochrome c1 remains unchanged. The close bind-
ing sites of stigmatellin and UHDBT to the [2Fe-2S] cluster in
the 3-dimensional structure provide a good explanation for
the e¡ect of these inhibitors on ISP (see Fig. 1). A similar
but smaller Em increase of the ISP was also reported for the
binding of UHDBT. In the presence of a 2.5-fold molar excess
of UHDBT the Em of the ISP becomes 350 mV at neutral pH
[21]. The shift of the Em of the ISP thus causes electron trans-
fer from cytochrome c1 to ISP if cytochrome c1 is in the
partially reduced state. The degree of cytochrome c1 oxidation
can be simply assessed by the K-absorption of reduced cyto-
chrome c1 at 553 nm. The inhibitor induced reduction of ISP
was also checked by a CD peak at 500 nm (data not shown).
Myxothiazol binds closer to cytochrome bL heme and causes
Fig. 1. Binding domains of stigmatellin and UHDBT in the Qo pocket of bovine cytochrome bc1 complex.
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some spectral change, but has no e¡ect on the Em of the ISP
[5]. MOA-stilbene slightly decreases the Em of the ISP, and
thus causes some reduction of cytochrome c1.
Taking advantage of the high electron transfer rate between
the ISP and cytochrome c1 and the elevation of the Em of ISP
upon the binding of stigmatellin or UHDBT, we measured the
rates of binding of these inhibitors to cytochrome bc1 complex
at various conditions by the conventional rapid mixing
stopped-£ow apparatus. It is assumed that pH and inhibitor
induced electron transfers proceed with the same high rate
and that inhibitor binding is the rate limiting step.
3.2. Determination of the binding rate constant of stigmatellin
to the cytochrome bc1 complex
Cytochrome c1 partially reduced cytochrome bc1 complex
was diluted in 20 mM Tris-HCl bu¡er, pH 8.3, containing
0.05% dodecyl maltoside and 0.1 M KCl to a cytochrome c1
concentration of around 15 WM. The diluted complex was
mixed with an equal volume of the bu¡er containing stigma-
tellin at room temperature in an Olis stopped-£ow rapid scan-
ning spectrophotometer. The oxidation of cytochrome c1 was
monitored by the decrease of absorption at 553 nm (see Fig.
2). The binding rates of stigmatellin to the cytochrome bc1
complex at pH 7.5, 8.3 and 9.2 were determined by following
the rates of cytochrome c1 oxidation. For each pH, the rates
were measured using several stigmatellin concentrations (5-,
10-, 15-fold molar excess of the inhibitor to the cytochrome
c1). The plot indicates the rates of cytochrome c1 oxidation
are stigmatellin concentration dependent. From the rates of
cytochrome c1 oxidation at various concentrations of stigma-
tellin, the second order binding rate constant for this inhibitor
at pH 7.5 was linearly ¢tted to be 1.0U105 M31 s31 (see Fig.
3). When the binding was determined at pH 8.3 and 9.2, the
rate constants were not signi¢cantly di¡erent from that at pH
7.5.
This pH independent binding rate constant indicates either
that no group with a pKa between 7.5 and 9.2 is involved in
the binding of stigmatellin to the cytochrome bc1 complex or
that the e¡ect of a given group on the binding is compensated
by the change of another group in the complex. A close con-
tact between stigmatellin and the [2Fe-2S] cluster is expected
because of the large increase of the Em of ISP upon its bind-
ing. Structural analysis of cytochrome bc1/inhibitor complex
reveals that the electron density of stigmatellin is strongly
connected to the [2Fe-2S] cluster at position H161 (Fig. 1).
This may represent a hydrogen bond between (protonated)
H161 ligand and a carbonyl and a methoxy group of stigma-
tellin or alternatively between deprotonated H161 and the
hydroxy group of the inhibitor. The hydrogen bonding is
responsible for holding the ISP in its ¢xed position [14].
3.3. Determination of the binding rate constant of UHDBT to
cytochrome bc1 complex:
Since binding of UHDBT also increases the Em of ISP and
has no e¡ect on that of cytochrome c1, binding kinetics of
UHDBT can also be followed by the oxidation of cytochrome
c1. Similar binding experiments as those described for stigma-
tellin were carried out. The binding rates of UHDBT to the
cytochrome bc1 complex at three pHs were measured by the
rates of cytochrome c1 oxidation. For each pH, the rates were
measured using several concentrations of UHDBT (5-, 10-,
17-, 23-fold molar excess of UHDBT to the cytochrome c1).
At pH 7.5 the rate constant for UHDBT binding was calcu-
lated to be 2.3 þ 0.2U105 M31 s31 (see Fig. 4). In contrast to
stigmatellin, the binding rate constant of UHDBT is pH de-
pendent. A 10-fold decrease in binding rate constant was ob-
tained when the binding was carried out at pH 9.2. At pH 8.3
the binding rate constant was 9.0 þ 1.1U104 M31 s31.
Although the pH dependence of the rate constant is most
likely due to ionization of the hydroxyl group of UHDBT, a
contribution of the protein is also important as pH dependent
inhibition of a bromo-substituted inhibitor (UBrDBT) is also
Fig. 2. Optical spectra and time trace obtained by stopped-£ow rap-
id scanning spectrophotometry during the binding of stigmatellin at
pH 8.3. Cytochrome bc1 complex was diluted in 20 mM Tris-HCl,
pH 8.3, containing 0.05% dodecyl maltoside and 100 mM KCl to a
cytochrome c1 concentration of 15 WM. The diluted complex was
mixed with an equal volume of the bu¡er containing 88 WM of stig-
matellin at room temperature in an Olis stopped-£ow rapid scan-
ning spectrophotometer. A: Representative traces showing the spec-
tral change of oxidation of cytochrome c1. B: The absorbance
changes at 553.4 nm were taken from the data in A to monitor the
rate of oxidation of heme c1.
Fig. 3. The binding rates of stigmatellin to the cytochrome bc1 com-
plex at various pHs. The binding rates were measured by cyto-
chrome c1 oxidation at pH 7.5 (a), 8.3 (b) and 9.2 (U) in the pres-
ence of di¡erent concentrations of the inhibitor. The experimental
condition is the same as that described in Fig. 2 except 7.5 WM of
cytochrome c1 and indicated amounts of stigmatellin were used. The
plots of the slope of linear ¢t gave a second order rate constant of
1.0U105 M31 s31 for stigmatellin binding. The rate of binding is
pH independent.
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observed [22]. The pH dependence correlated well with the
inhibitory e¡ect of UHDBT. The pKa for the weak acid hy-
droxyl group of UHDBT was reported to be 6.5 [7].
From the structure of the cytochrome bc1 complex, it is
clear that quinone substrate or inhibitors reach their binding
site through a common entrance, which is buried in or sur-
rounded by phospholipid [11]. The amino acid residues sur-
rounding the entrance and on the passage leading to the bind-
ing domains are generally hydrophobic. When pH is higher
than the pKa, UHDBT would be charged and unable to access
the binding site. The binding site of UHDBT is on the edge of
the Qo pocket in cytochrome b and close to the [2Fe-2S]
center.
The anomalous scattering data indicate that in the fully
oxidized cytochrome bc1 complex less than 50% of the ISP
is present in the ¢xed position [11], 31 Aî from heme c1, the
rest are in the loose or released positions, somewhere between
the ‘¢xed’ (or ‘b’) and the ‘c1’ positions [13,14]. In the partially
reduced cytochrome bc1 complex the location of the [2Fe-2S]
cluster is not yet ¢rmly established. Preliminary results suggest
that in the partially reduced complex the [2Fe-2S] cluster is
located mostly at the loose or released positions because the
electron density of the [2Fe-2S] cluster at the ‘¢xed’ position is
greatly diminished in the anomalous scattering map of the
partially reduced cytochrome bc1 complex. In the absence of
UHDBT or stigmatellin, the pH induced electron transfer
between the [2Fe-2S] cluster and heme c1, either the acid in-
duced cytochrome c1 oxidation or the base induced cyto-
chrome c1 reduction [20], is very fast suggesting that ISP is
constantly under rapid moving at the di¡erent released posi-
tions. The pH induced electron transfer becomes very slow if
cytochrome bc1 complex is treated with UHDBT or stigma-
tellin before the pH jump. This con¢rms that these inhibitors
arrest the head domain of ISP to the ¢xed [11,12] or b posi-
tion [14] regardless of whether the [2Fe-2S] cluster or heme c1
is in the reduced or oxidized state. For kinetic analysis several
events should be considered, including the inhibitor induced
electron transfer from heme c1 to the [2Fe-2S] cluster, the
interaction of the complex with the inhibitor when ISP is at
the released positions and the movement of the ISP from the
released positions to the ¢xed position in the inhibitor loaded
complex. Apparently the electron transfer from heme c1 to the
[2Fe-2S] cluster in the cytochrome bc1/inhibitor complex takes
place before the [2Fe-2S] cluster moves to the ¢xed position.
Therefore the observed rate constant of cytochrome c1 oxida-
tion is Kon for the binding of the inhibitor to the Qo pocket.
Complex molecules with their ISP at ¢xed position are not
able to accept electron from heme c1 when they interact with
inhibitor because of the long distance between the two redox
centers. Therefore the measured rate constants may be lower
than the actual ones, as the interaction of the complex mole-
cules with ISP at ¢xed position is not accounted for.
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Fig. 4. The binding rates of UHDBT to the cytochrome bc1 com-
plex at various pHs. The experimental condition is the same as that
described in Fig. 3 except for the presence of di¡erent concentra-
tions of UHDBT. The binding of UHDBT is inhibitor concentra-
tion and pH dependent. The second order rate constants for
UHDBT binding were 2.3 þ 0.2U105 M31 s31 at pH 7.5 (a) ;
9.0 þ 1.1U104 M31 s31 at pH 8.3 (b) and 2.3 þ 0.1U104 M31 s31 at
pH 9.2 (U).
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